These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 34685018)

  • 1. The State of the Art of Theranostic Nanomaterials for Lung, Breast, and Prostate Cancers.
    Freitas LF; Ferreira AH; Thipe VC; Varca GHC; Lima CSA; Batista JGS; Riello FN; Nogueira K; Cruz CPC; Mendes GOA; Rodrigues AS; Sousa TS; Alves VM; Lugão AB
    Nanomaterials (Basel); 2021 Sep; 11(10):. PubMed ID: 34685018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current progress of nanomedicine for prostate cancer diagnosis and treatment.
    Zhao J; Zhang C; Wang W; Li C; Mu X; Hu K
    Biomed Pharmacother; 2022 Nov; 155():113714. PubMed ID: 36150309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of nanomaterials as drug delivery systems and anticancer agents in the treatment of triple-negative breast cancer: an updated review (year 2005 to date).
    Ndongwe T; Zhou AA; Ganga NP; Matawo N; Sibanda U; Chidziwa TV; Witika BA; Krause RWM; Matlou GG; Siwe-Noundou X
    Discov Nano; 2024 Sep; 19(1):138. PubMed ID: 39225730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities.
    Siafaka PI; Okur NÜ; Karantas ID; Okur ME; Gündoğdu EA
    Asian J Pharm Sci; 2021 Jan; 16(1):24-46. PubMed ID: 33613728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric multifunctional nanomaterials for theranostics.
    Peng H; Liu X; Wang G; Li M; Bratlie KM; Cochran E; Wang Q
    J Mater Chem B; 2015 Sep; 3(34):6856-6870. PubMed ID: 32262535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
    Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
    Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances and Implication of Bioengineered Nanomaterials in Cancer Theranostics.
    Rai A; Noor S; Ahmad SI; Alajmi MF; Hussain A; Abbas H; Hasan GM
    Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33494239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advancement of Nanotheranostics in Cancer Applications.
    Parveen S; Abira R; Paikray S; Sahoo L; Tripathy NS; Dilnawaz F
    Curr Drug Deliv; 2024 May; ():. PubMed ID: 38812425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Going even smaller: Engineering sub-5 nm nanoparticles for improved delivery, biocompatibility, and functionality.
    Xie M; Xu Y; Huang J; Li Y; Wang L; Yang L; Mao H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Nov; 12(6):e1644. PubMed ID: 32432393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-Targeted Surface-Engineered Nanomaterials for Breast Cancer Imaging and Theranostic Applications.
    Ahmad J; Rizwanullah M; Suthar T; Albarqi HA; Ahmad MZ; Vuddanda PR; Khan MA; Jain K
    Crit Rev Ther Drug Carrier Syst; 2022; 39(6):1-44. PubMed ID: 35997100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique roles of nanotechnology in medicine and cancer-II.
    Alam F; Naim M; Aziz M; Yadav N
    Indian J Cancer; 2015; 52(1):1-9. PubMed ID: 26837958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad-Spectrum Theranostics and Biomedical Application of Functionalized Nanomaterials.
    Alshamrani M
    Polymers (Basel); 2022 Mar; 14(6):. PubMed ID: 35335551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural-Engineering Rationales of Gold Nanoparticles for Cancer Theranostics.
    Chen W; Zhang S; Yu Y; Zhang H; He Q
    Adv Mater; 2016 Oct; 28(39):8567-8585. PubMed ID: 27461909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and Surface Modification of Polymeric Nanoparticles for Drug Delivery: State of the Art.
    Joshi G; Patel M; Chaudhary D; Sawant K
    Recent Pat Drug Deliv Formul; 2020; 14(3):201-213. PubMed ID: 32885767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
    Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green Synthesized Nanomaterials as Theranostic Platforms for Cancer Treatment: Principles, Challenges and the Road Ahead.
    Rajasekharreddy P; Huang C; Busi S; Rajkumari J; Tai MH; Liu G
    Curr Med Chem; 2019; 26(8):1311-1327. PubMed ID: 28294042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smart Nanomaterials in Cancer Theranostics: Challenges and Opportunities.
    Kashyap BK; Singh VV; Solanki MK; Kumar A; Ruokolainen J; Kesari KK
    ACS Omega; 2023 Apr; 8(16):14290-14320. PubMed ID: 37125102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optically active organic and inorganic nanomaterials for biological imaging applications: A review.
    Sowmiya P; Dhas TS; Inbakandan D; Anandakumar N; Nalini S; Suganya KSU; Remya RR; Karthick V; Kumar CMV
    Micron; 2023 Sep; 172():103486. PubMed ID: 37262930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinspired theranostic quantum dots: Paving the road to a new paradigm for cancer diagnosis and therapeutics.
    Mazahir F; Sharma R; Yadav AK
    Drug Discov Today; 2023 Dec; 28(12):103822. PubMed ID: 37949429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.